Maven exits Healthpoint in trade sale
Maven Capital Partners has sold consumer healthcare and beauty supplier Healthpoint to Dutch wholesaler Dayes for a 3.1x return.Т
The private equity firm bought Healthpoint in February 2017 for GBP 6.5m in a management buyout. The deal was funded through Maven's co-investment network Maven Investor Partners, with debt and working capital provided by Barclays.
Accounts show that Healthpoint had revenues of GBP 18.5m in the year ending in March 2021, up 1.6% on the year prior.
Dayes, formerly known as Nedac Sorbo Mascot, was bought by H2 Equity Partners in February 2019.
Company
Healthpoint was founded in 1996. It supplies personal care and beauty products to affordable UK high-street retailers including Home Bargains, Savers, Superdrug and Bodycare. 
It has also built up its own portfolio of branded products, including 'Derma V10' and 'Clear & Simple'.
People
Maven - Ryan Bevington (partner).
Healthpoint - Amanda Parkinson (managing director).
Advisers 
Vendor - KPMG (M&A); Ward Hadaway (legal); Mazars (financial due diligence).
Buyer - Clearwater International (M&A); Squire Patton Boggs (legal); EY (financial due diligence); BHP (tax). 
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








